arrow
T

Tatu Pantsar

University of Eastern Finland
H指数:15
被引数:2,431

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

PIP4K2C inhibition reverses autophagic flux impairment induced by SARS-CoV-2

Karim, M.; Mishra, M.; Lo, C.W.; Saul, S.; Cagirici, H.; Gourdelier, M.; Ghita, L.; Ojha, A.; Tran, D.H.N.; Agrawal, A.; et al. PIP4K2C抑制逆转由SARS-CoV-2引起的自噬流障碍。Nat. Commun. 2025, 16, 6397. [Google Scholar] [CrossRef]

2025-07-100
OAAI
Beyond KRAS(G12C): Biochemical and Computational Characterization of Sotorasib and Adagrasib Binding Specificity and the Critical Role of H95 and Y96

超越KRAS(G12C): Sotorasib和Adagrasib结合特异性的生化和计算表征以及H95和Y96的关键作用

2024-09-161
PRE
Development and characterization of kinase sparing TPX2-tethering Aurora kinase A ligands for cancer therapy
2024-03-220
PRE
Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation Modulation

用于血小板脱颗粒调节的一流ACKR3/CXCR7超激动剂的发现和开发

2022-09-237
PRE
Bioisosteric Replacement of Arylamide-Linked Spine Residues with N-Acylhydrazones and Selenophenes as a Design Strategy to Novel Dibenzosuberone Derivatives as Type I 1/2 p38α MAP Kinase Inhibitors

用N-酰基hydr和硒酚生物等排取代芳基酰胺连接的脊柱残基,作为新型二苯并环酮衍生物作为I型1/2 p38α MAP激酶抑制剂的设计策略

2020-05-2814
PREAI
Design, synthesis, and biological evaluation of 2,4-dihydropyrano[2,3-c]pyrazole derivatives as autotaxin inhibitors

自分泌运动因子抑制剂2,4-二氢吡喃并 [2,3-c] 吡唑衍生物的设计、合成及生物学评价

2017-09-0111
PREAI
A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer

Myc-aurora激酶A蛋白复合物代表p53-altered肝癌的可行药物靶标

2016-05-23223
PREAI